Andrew Arno Oncocyte Corp (OCX) insider trading activity
Andrew Arno is Director of Oncocyte Corp. Currently has a direct ownership of 136,554 shares of OCX, which is worth approximately $387,813. The most recent transaction as insider was on Jul 01, 2025, when has been sold 55,000 shares (Common Stock, No Par Value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
137K
67.44%
3M change
97.75%
12M change
Total Value Held
$387,813
Andrew Arno Transaction History
Also insider at
AA
Andrew Arno
Director
Irvine, CA